Supporting Materials Annual Meeting Notice and Proxy Statement 474 KB Notice 145.2 KB Proxy Card 52 KB Eagle Pharmaceuticals Inc. 2024 and 2023 Audited Financials 663.1 KB Unaudited First Quarter 2025 Financial Statements 453.8 KB Unaudited Second Quarter 2025 Financial Statements 411.7 KB